Melanoma / Skin

General Information



Photodynamic therapy for prevention of non-melanoma


Adult


NCT02751151


The study will draw patients from the Transplant Dermatology specialty clinic, where the investigators see organ transplant recipients (OTR) for regular screening and serve as a regional referral center for this population. Enrollment will be limited to 20 patients. Inclusion criteria are organ transplant recipients status, active immunosuppression for at least 5 years, and history of at least one NMSC.


Inova Schar Cancer Institute
8081 Innovation Park Drive
Fairfax, VA 22031
A department of Inova Fairfax Hospital

Eligibility Information

The study will draw patients from the Transplant Dermatology specialty clinic, where the investigators see organ transplant recipients (OTR) for regular screening and serve as a regional referral center for this population. Enrollment will be limited to 20 patients. Inclusion criteria are organ transplant recipients status, active immunosuppression for at least 5 years, and history of at least one NMSC.

Ineligibility Information

  • Patient is not appropriate candidate for treatment or research trial per treating physician
  • Patient has a mental health condition that makes them unable to participate in this research trial, per PI judgment.
  • Patient is on additional immunosuppression for diagnosis unrelated to organ transplant

Contact Information


Kelly Jeffords, CCRP


571-472-0631


kelly.jeffords@inova.org

Additional information can be found at https://clinicaltrials.gov/ct2/show/NCT02751151